» Articles » PMID: 38745035

Association Between Dietary Consumption of Fatty Acids and Age-related Macular Degeneration in the National Health and Nutrition Examination Survey

Overview
Journal Sci Rep
Specialty Science
Date 2024 May 14
PMID 38745035
Authors
Affiliations
Soon will be listed here.
Abstract

The aim of this study is to assess the relationship between dietary intake of fatty acids and the age-related macular degeneration (AMD) in the United States population. Adult participants of the 2005-2008 National Health and Nutrition Examination Survey (NHANES) were included in this nationwide cross-sectional study. Dietary fatty acid intake was obtained from two 24-h dietary recall interviews. The intake of dietary fatty acids was analyzed as a continuous and categorical variable. AMD status was assessed using nonmydriatic fundus photographs. Univariate and multivariate logistic regression analyses were used to assess the association between dietary fatty acid intake and AMD. The unweighted population included 4702 individuals of whom 374 had AMD. After adjusting for relevant variables, each 1 unit increase (1 mg/1000 kcal) intake of EPA (OR: 0.996, 95% CI: 0.993-0.996, P = 0.018), DPA (OR: 0.976, 95% CI: 0.962-0.990, P = 0.002), and DHA (OR: 0.996, 95% CI: 0.994-0.999, P = 0.003) were significantly decreased odds of any AMD. The highest versus lowest quartile of EPA (OR: 0.476, P for trend < 0.001), DPA (OR: 0.467, P for trend = 0.005) and DHA (OR: 0.586, P for trend = 0.008) were negatively associated with the odds of any AMD. Subgroup analysis showed that higher quartiles of EPA (OR: 0.461, P for trend < 0.002), DPA (OR: 0.467, P for trend = 0.006) and DHA (OR: 0.578, P for trend = 0.007) exhibited a negative association with early AMD. The study found no significant association between the intake of dietary fatty acids, including n-3 PUFA, and the odds of late AMD. In the 2005-2008 NHANES population, higher dietary DHA, DPA and EPA intake associated with decreased odds of early AMD. However, no clear association was found between specific types of FAs and late AMD.

Citing Articles

A cross-sectional observational study of the association between biochemistry profiles and the risk of age-related macular degeneration.

Bai S, Zhang L, Yan W, Wang H Sci Rep. 2025; 15(1):8588.

PMID: 40075135 PMC: 11904207. DOI: 10.1038/s41598-025-89121-x.


Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA): A Targeted Antioxidant Strategy to Counter Oxidative Stress in Retinopathy.

Zeppieri M, Gagliano C, DEsposito F, Musa M, Gattazzo I, Zanella M Antioxidants (Basel). 2025; 14(1).

PMID: 39857340 PMC: 11759855. DOI: 10.3390/antiox14010006.


Co-delivery of antioxidants and siRNA-VEGF: promising treatment for age-related macular degeneration.

Dias M, Cruz-Cazarim E, Pittella F, Baiao A, Pacheco A, Sarmento B Drug Deliv Transl Res. 2025; .

PMID: 39751765 DOI: 10.1007/s13346-024-01772-x.


Machine learning model for age-related macular degeneration based on heavy metals: The National Health and Nutrition Examination Survey 2005 to 2008.

Gao X, Liu C, Yin L, Wang A, Li J, Gao Z Sci Rep. 2024; 14(1):26913.

PMID: 39506000 PMC: 11541880. DOI: 10.1038/s41598-024-78412-4.


Associations between eicosapentaenoic acid and docosahexaenoic acid consumption and inflammatory bowel disease in adults: The National Health and Nutrition Examination Survey (NHANES) 2009-2010.

Wang Y, Dou P, Pan Y Asia Pac J Clin Nutr. 2024; 33(4):562-568.

PMID: 39209366 PMC: 11389807. DOI: 10.6133/apjcn.202412_33(4).0011.

References
1.
Arslan S, Kadayifcilar S, Samur G . The Potential Role of Dietary Antioxidant Capacity in Preventing Age-Related Macular Degeneration. J Am Coll Nutr. 2018; 38(5):424-432. DOI: 10.1080/07315724.2018.1538830. View

2.
Kennedy E, Bowman S, Powell R . Dietary-fat intake in the US population. J Am Coll Nutr. 1999; 18(3):207-12. DOI: 10.1080/07315724.1999.10718853. View

3.
Ren J, Ren A, Deng X, Huang Z, Jiang Z, Li Z . Long-Chain Polyunsaturated Fatty Acids and Their Metabolites Regulate Inflammation in Age-Related Macular Degeneration. J Inflamm Res. 2022; 15:865-880. PMC: 8842733. DOI: 10.2147/JIR.S347231. View

4.
Weikel K, Chiu C, Taylor A . Nutritional modulation of age-related macular degeneration. Mol Aspects Med. 2012; 33(4):318-75. PMC: 3392439. DOI: 10.1016/j.mam.2012.03.005. View

5.
. Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial. JAMA. 2013; 309(19):2005-15. DOI: 10.1001/jama.2013.4997. View